Predicting Lymph Node Metastasis From Primary Cervical Squamous Cell Carcinoma Based on Deep Learning in Histopathologic Images.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published Date:

Abstract

We developed a deep learning framework to accurately predict the lymph node status of patients with cervical cancer based on hematoxylin and eosin-stained pathological sections of the primary tumor. In total, 1524 hematoxylin and eosin-stained whole slide images (WSIs) of primary cervical tumors from 564 patients were used in this retrospective, proof-of-concept study. Primary tumor sections (1161 WSIs) were obtained from 405 patients who underwent radical cervical cancer surgery at the Fudan University Shanghai Cancer Center (FUSCC) between 2008 and 2014; 165 and 240 patients were negative and positive for lymph node metastasis, respectively (including 166 with positive pelvic lymph nodes alone and 74 with positive pelvic and para-aortic lymph nodes). We constructed and trained a multi-instance deep convolutional neural network based on a multiscale attention mechanism, in which an internal independent test set (100 patients, 228 WSIs) from the FUSCC cohort and an external independent test set (159 patients, 363 WSIs) from the Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cohort of the Cancer Genome Atlas program database were used to evaluate the predictive performance of the network. In predicting the occurrence of lymph node metastasis, our network achieved areas under the receiver operating characteristic curve of 0.87 in the cross-validation set, 0.84 in the internal independent test set of the FUSCC cohort, and 0.75 in the external test set of the Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma cohort of the Cancer Genome Atlas program. For patients with positive pelvic lymph node metastases, we retrained the network to predict whether they also had para-aortic lymph node metastases. Our network achieved areas under the receiver operating characteristic curve of 0.91 in the cross-validation set and 0.88 in the test set of the FUSCC cohort. Deep learning analysis based on pathological images of primary foci is very likely to provide new ideas for preoperatively assessing cervical cancer lymph node status; its true value must be validated with cervical biopsy specimens and large multicenter datasets.

Authors

  • Qinhao Guo
    Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Linhao Qu
    Digital Medical Research Center, School of Basic Medical Science, Fudan University, Shanghai Key Lab of Medical Image Computing and Computer Assisted Intervention, Shanghai 200032, People's Republic of China.
  • Jun Zhu
    Sinopharm Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei, 442008, China.
  • Haiming Li
    Department of Radiology, Fudan University Shanghai Cancer Center, 270 Dongan Road, Shanghai, 200032, People's Republic of China.
  • Yong Wu
    Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Soochow University, Suzhou City, Jiangsu Province, People's Republic of China.
  • Simin Wang
    Cyberspace Institute of Advanced Technology (CIAT), Guangzhou University, Guangzhou 510006, China.
  • Min Yu
    From the Division of Laboratory Medicine, Department of Pathology, University of Virginia School of Medicine and Health System, Charlottesville. Dr Yu is currently located in the Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center, Lexington.
  • Jiangchun Wu
    Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Hao Wen
  • Xingzhu Ju
    Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Xin Wang
    Key Laboratory of Bio-based Material Science & Technology (Northeast Forestry University), Ministry of Education, Harbin 150040, China.
  • Rui Bi
    Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Department of Pathology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China. Electronic address: br_fdcc@163.com.
  • Yonghong Shi
    School of Basic Medical Sciences, Digital Medical Research Center, Fudan University, Shanghai, China. yonghong.shi@fudan.edu.cn.
  • Xiaohua Wu
    School of Art and Design, Sanming University, Sanming, Fujian, China.